Terms: = Liver cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
56 results:
1. Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors - a systematic review and meta-analysis.
Dawood ZS; Brown ZJ; Alaimo L; Lima HA; Shaikh C; Katayama ES; Munir MM; Moazzam Z; Endo Y; Woldesenbet S; Pawlik TM
HPB (Oxford); 2024 May; 26(5):618-629. PubMed ID: 38369433
[TBL] [Abstract] [Full Text] [Related]
2. Role of TOP2A and CDC6 in liver cancer.
Jia W; Liu X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
[TBL] [Abstract] [Full Text] [Related]
3. A predictive scoring model to select suitable patients for surgery on primary tumor in metastatic esophageal cancer.
Wei L; Xu J; Hu X; Xie Y; Lyu G
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1898. PubMed ID: 37702247
[TBL] [Abstract] [Full Text] [Related]
4. Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
Lei Z; Ma W; Si A; Zhang Y; Yang F; Yu Q; Tang H; Xiao Q; Zhou J; Wang K; Tang Y; Han T; Yin G; Chen J; Liu X; Zhao H; Yu D; Luo T; Wang Q; Yan M; Mao X; Li J; Wang K; Li J; Zeng Y; Ding D; Chen T; Wu X; Xia Y; Wang K; Guo W; Zhu G; Gao S; Hüser N; Lau WY; Song T; Cheng S; Shen F; Cheng Z
Aliment Pharmacol Ther; 2023 Sep; 58(6):611-622. PubMed ID: 37349908
[TBL] [Abstract] [Full Text] [Related]
5. Risk Factors for Hyperuricemia or Gout in Men and Women: The Circulatory Risk in Communities Study (CIRCS).
Teramura S; Yamagishi K; Umesawa M; Hayama-Terada M; Muraki I; Maruyama K; Tanaka M; Kishida R; Kihara T; Takada M; Ohira T; Imano H; Shimizu Y; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H
J Atheroscler Thromb; 2023 Oct; 30(10):1483-1491. PubMed ID: 36878531
[TBL] [Abstract] [Full Text] [Related]
6. Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma.
Xin HY; Sun RQ; Zou JX; Wang PC; Wang JY; Ye YH; Liu KX; Hu ZQ; Zhou ZJ; Fan J; Zhou J; Zhou SL
JAMA Netw Open; 2023 Mar; 6(3):e231476. PubMed ID: 36867406
[TBL] [Abstract] [Full Text] [Related]
7. Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib treatment: A Real-World Study.
Chen B; Zhang L; Cheng J; Wu T; Lei J; Yang X; Zhang R; Safadi R; Li Y; Si T; Lu Y
Drug Des Devel Ther; 2022; 16():4429-4437. PubMed ID: 36597443
[TBL] [Abstract] [Full Text] [Related]
8. Machine Learning Predictive Model to Guide treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
Famularo S; Donadon M; Cipriani F; Fazio F; Ardito F; Iaria M; Perri P; Conci S; Dominioni T; Lai Q; La Barba G; Patauner S; Molfino S; Germani P; Zimmitti G; Pinotti E; Zanello M; Fumagalli L; Ferrari C; Romano M; Delvecchio A; Valsecchi MG; Antonucci A; Piscaglia F; Farinati F; Kawaguchi Y; Hasegawa K; Memeo R; Zanus G; Griseri G; Chiarelli M; Jovine E; Zago M; Abu Hilal M; Tarchi P; Baiocchi GL; Frena A; Ercolani G; Rossi M; Maestri M; Ruzzenente A; Grazi GL; Dalla Valle R; Romano F; Giuliante F; Ferrero A; Aldrighetti L; Bernasconi DP; Torzilli G;
JAMA Surg; 2023 Feb; 158(2):192-202. PubMed ID: 36576813
[TBL] [Abstract] [Full Text] [Related]
9. Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma.
Xu W; Nie C; Lv H; Chen B; Wang J; Wang S; Zhao J; He Y; Chen X
Front Immunol; 2022; 13():1010554. PubMed ID: 36275697
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal cancer: A Systematic Review and Meta-Analysis.
Meyer HJ; Strobel A; Wienke A; Surov A
Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
[TBL] [Abstract] [Full Text] [Related]
11. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
[TBL] [Abstract] [Full Text] [Related]
12. INZ-701, a recombinant ENPP1 enzyme, prevents ectopic calcification in an Abcc6
Jacobs IJ; Cheng Z; Ralph D; O'Brien K; Flaman L; Howe J; Thompson D; Uitto J; Li Q; Sabbagh Y
Exp Dermatol; 2022 Jul; 31(7):1095-1101. PubMed ID: 35511611
[TBL] [Abstract] [Full Text] [Related]
13. Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection.
Wang XH; Hu ZL; Fu YZ; Hou JY; Li WX; Zhang YJ; Xu L; Zhou QF; Chen MS; Zhou ZG
J Gastroenterol; 2022 Mar; 57(3):185-198. PubMed ID: 35152312
[TBL] [Abstract] [Full Text] [Related]
14. Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
Veelken R; Maiwald B; Strocka S; Petersen TO; Moche M; Ebel S; Denecke T; Rehak M; Struck MF; Forstmeyer D; Rademacher S; Seehofer D; Berg T; van Bömmel F
Cardiovasc Intervent Radiol; 2022 Feb; 45(2):218-222. PubMed ID: 34716470
[TBL] [Abstract] [Full Text] [Related]
15. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
16. Expression and prognosis analyses of BUB1, bub1b and BUB3 in human sarcoma.
Long Z; Wu T; Tian Q; Carlson LA; Wang W; Wu G
Aging (Albany NY); 2021 Apr; 13(9):12395-12409. PubMed ID: 33872216
[TBL] [Abstract] [Full Text] [Related]
17. Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
Casadei-Gardini A; Scartozzi M; Tada T; Yoo C; Shimose S; Masi G; Lonardi S; Frassineti LG; Nicola S; Piscaglia F; Kumada T; Kim HD; Koga H; Vivaldi C; Soldà C; Hiraoka A; Bang Y; Atsukawa M; Torimura T; Tsuj K; Itobayashi E; Toyoda H; Fukunishi S; Rimassa L; Rimini M; Cascinu S; Cucchetti A
Liver Int; 2021 Jun; 41(6):1389-1397. PubMed ID: 33547848
[TBL] [Abstract] [Full Text] [Related]
18. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
19. Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study.
Primrose JN; Pugh SA; Thomas G; Ellis M; Moutasim K; Mant D
Health Technol Assess; 2021 Jan; 25(2):1-32. PubMed ID: 33416473
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial cancer: The Canadian cancer Trials Group BL.12 Randomized Clinical Trial.
Sridhar SS; Blais N; Tran B; Reaume MN; North SA; Stockler MR; Chi KN; Fleshner NE; Liu G; Robinson JW; Mukherjee SD; Rahim Y; Winquist E; Booth CM; Nguyen NT; Beardsley EK; Alimohamed NS; McDonald GT; Ding K; Parulekar WR
JAMA Oncol; 2020 Nov; 6(11):1751-1758. PubMed ID: 32940628
[TBL] [Abstract] [Full Text] [Related]
[Next]
